Skip to main content

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
Cancel
×
×
Home
  • Home
Chapter
  • Print publication year: 2014
  • Online publication date: April 2014

Chapter 25 - Gastrointestinal complications of movement disorders

from Section V - Systemic complications of movement disorders
Export citation
Summary

Introduction

Gastrointestinal (GI) symptoms often accompany movement disorders, either as a result of the primary disorder or as a side effect of pharmacotherapy. Recognition of GI symptoms requires vigilance on the part of clinicians, and differentiating GI symptoms caused by the underlying disease from those that are side effects of medications necessitates a thoughtful approach. Directed questions about GI symptoms should be asked routinely during clinic visits in order to identify and subsequently address these vexing and potentially dangerous problems. This chapter aims to assist clinicians in this important endeavor by providing a review of the available literature on GI complications of movement disorders, as well as concise information on the most common GI side effects of movement disorder medications. Information on the work-up and management of GI complications is also presented where appropriate. The movement disorders covered in this chapter are those for which there is a body of medical literature on associated GI complications. Readers should note that the available literature on this topic is exceedingly limited for all movement disorders except Parkinson’s disease, making the information presented herein far from complete.

Parkinson’s disease

GI symptoms, which reflect dysregulation of GI motility, are highly prevalent in PD. Aside from their negative impact on quality of life, GI symptoms in PD can be associated with life-threatening complications, including malnutrition, pulmonary aspiration, megacolon, and intestinal obstruction; furthermore, they frequently lead to emergency admissions in the PD population (Visser et al. 2008; Barone et al. 2009; Guneysel et al. 2008; Caplan et al. 1965). GI symptoms also have the potential to affect other PD symptoms. For example, gastroparesis and subsequent late arrival at intestinal absorption sites can lead to erratic absorption of levodopa with resultant motor fluctuations (Djaldetti et al. 1996; Kurlan et al. 1988). The pathophysiological underpinnings of the deranged gut motility in PD are not known. Alpha-synuclein pathology has been demonstrated in colonic submucosa from subjects with early, untreated PD and in a small number of subjects prior to PD diagnosis (Shannon et al. 2012a; Shannon et al. 2012b). While this finding has implicated colonic alpha-synuclein pathology as a potential biomarker for premotor PD, the pathology has yet to be correlated with objective motility data or subjective GI symptoms. The most commonly occurring GI symptoms in PD are weight loss, sialorrhea, dysphagia, nausea, constipation, and defecatory dysfunction, each of which is discussed separately.

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Movement Disorders in Neurologic and Systemic Disease
  • Online ISBN: 9781139175845
  • Book DOI: https://doi.org/10.1017/CBO9781139175845
Please enter your name
Please enter a valid email address
Who would you like to send this to *

CAPTCHA *

Skip to the audio challenge
×
References
Abbott, R. A., Cox, M., Markus, H., and Tomkins, A. (1992). “Diet, body size and micronutrient status in Parkinson’s disease,” Eur. J. Clin. Nutr. 46(12): 879–84.
Abbott, R. D., Petrovitch, H., White, L. R., Masaki, K. H., Tanner, C. M., Curb, J. D., et al. (2001). “Frequency of bowel movements and the future risk of Parkinson’s disease,” Neurology 57(3): 456–62.
Ali, G. N., Wallace, K. L., Schwartz, R., DeCarle, D. J., Zagami, A. S., and Cook, I. J. (1996). “Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson’s disease,” Gastroenterology 110(2): 383–92.
Andrich, J. E., Wobben, M., Klotz, P., Goetze, O., and Saft, C. (2009). “Upper gastrointestinal findings in Huntington’s disease: patients suffer but do not complain,” J. Neural Transm. 116(12): 1607–11.
Arbouw, M. E., Movig, K. L., Koopmann, M., Poels, P. J., Guchelaar, H. J., Egberts, T. C., et al. (2010). “Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial,” Neurology 74(15): 1203–7.
Ashraf, W., Pfeiffer, R., Park, F., Lof, J., and Quigley, E. M. (1997). “Constipation in Parkinson’s disease: objective assessment and response to psyllium,” Mov. Disord. 12(6): 946–51.
Aziz, N. A., Anguelova, G. V., Marinus, J., van Dijk, J. G., and Roos, R. A. (2010). “Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington’s disease,” Eur. J. Neurol. 17(8): 1068–74.
Aziz, N. A., van der Burg, J. M., Landwehrmeyer, G. B., Brundin, P., Stijnen, T., and Roos, R. A. (2008). “Weight loss in Huntington disease increases with higher CAG repeat number,” Neurology 71(19): 1506–13.
Barone, P., Antonini, A., Colosimo, C., Marconi, R., and Morgante, L. (2009). “The PRIAMO study: a multicenter assessment of non-motor symptoms and their impact on quality of life in Parkinson’s disease,” Mov. Disord. 24(11): 1641–9.
Bassotti, G., Germani, U., Pagliaricci, S., Plesa, A., Giulietti, O., Mannarino, E., et al. (1998). “Esophageal manometric abnormalities in Parkinson’s disease,” Dysphagia 13(1): 28–31.
Basu, P. P., Shah, N. J., Krishnaswamy, N., and Pacana, T. (2011). “Prevalence of restless legs syndrome in patients with irritable bowel syndrome,” World J. Gastroenterol. 17(39): 4404–7.
Bird, M. R., Woodward, M. C., Gibson, E. M., Phyland, D. J., and Fonda, D. (1994). “Asymptomatic swallowing disorders in elderly patients with Parkinson’s disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients,” Age & Ageing 23(3): 251–4.
Blonsky, E. R., Logemann, J. A., Boshes, B., and Fisher, H. B. (1975). “Comparison of speech and swallowing function in patients with tremor disorders and in normal geriatric patients: a cinefluorographic study,” J. Gerontol. 30(3): 299–303.
Bushmann, M., Dobmeyer, S. M., Leeker, L., and Perlmutter, J. S. (1989). “Swallowing abnormalities and their response to treatment in Parkinson’s disease,” Neurology 39(10): 1309–14.
Cadeddu, F., Bentivoglio, A., Brandara, F., Maringa, G., Brisinda, G., and Maria, G. (2005). “Outlet type constipation in Parkinson’s disease: results of botulinum toxin treatment,” Aliment. Pharmacol. Ther. 22(10): 997–1003.
Caplan, L. H., Jacobson, H. G., Rubinstein, B. M., and Rotman, M. Z. (1965). “Megacolon and volvulus in Parkinson’s disease,” Radiology 85: 73–9.
Castell, J. A., Johnston, B. T., Colcher, A., Li, Q., Gideon, R. M., and Castell, D. O. (2001). “Manometric abnormalities of the oesophagus in patients with Parkinson’s disease,” J. Neurogastroenterol. Motil. 13(4): 361–4.
Ciucci, M. R., Barkmeier-Kraemer, J. M., and Sherman, S. J. (2008). “Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson’s disease,” Mov. Disord. 23(5): 676–83.
Cloud, L. J. and Greene, J. G. (2011). “Gastrointestinal features of Parkinson’s disease,” Curr. Neurol. Neurosci. Rep. 11(4): 379–84.
Colosimo, C., Morgante, L., Antonini, A., Barone, P., Avarello, T. P., Bottacchi, E., et al. (2010). “Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study,” J. Neurol. 257(1): 5–14.
Correa, S. M., Felix, V. N., Gurgel, J. L., Sallum, R. A., and Cecconello, I. (2010). “Clinical evaluation of oropharyngeal dysphagia in Machado-Joseph disease,” Arq. Gastroenterol. 47(4): 334–8.
Djaldetti, R., Baron, J., Ziv, I., and Melamed, E. (1996). “Gastric emptying in Parkinson’s disease: patients with and without response fluctuations,” Neurology 46(4): 1051–4.
Drummond, S. and Kirkpatrick, A. (2004). “Speech and swallowing performances in tardive dyskinesia: a case study,” J. Med. Speech Lang. Pathol. 12: 9–19.
Durrieu, G., Llau, M. E., Rascol, O., Senard, J. M., Rascol, A., and Montastruc, J. L. (1992). “Parkinson’s disease and weight loss: a study with anthropometric and nutritional assessment,” Clin. Auton. Res. 2(3): 153–7.
Eadie, M. and Tyrer, J. H. (1965). “Alimentary disorders in parkinsonism,” Aust. Ann. Med. 14: 13–22.
Edwards, L. L., Pfeiffer, R. F., Quigley, E. M., Hofman, R., and Balluff, M. (1991). “Gastrointestinal symptoms in Parkinson’s disease,” Mov. Disord. 6(2): 151–6.
Edwards, L. L., Quigley, E. M., Harned, R. K., Hofman, R., and Pfeiffer, R. (1993). “Defecatory function in Parkinson’s disease: response to apomorphine,” Ann. Neurol. 33(5): 490–3.
Edwards, L. L., Quigley, E. M., Hofman, R., and Pfeiffer, R. F. (1993). “Gastrointestinal symptoms in Parkinson’s disease: an 18-month follow-up study,” Mov. Disord. 8(1): 83–6.
Eichhorn, T. and Oertel, W. (2001). “Macrogol 3350/electrolyte improves constipation in Parkinson’s disease and multiple system atrophy,” Mov. Disord. 16(6): 1176–7.
Fernagut, P. O., Vital, A., Canron, M. H., Tison, F., and Meissner, W. G. (2012). “Ambiguous mechanisms of dysphagia in multiple system atrophy,” Brain 135(Pt. 2): e205; author reply e206.
Fève, A., Angelard, B., and Guily, J. (1995). “Laryngeal tardive dyskinesia,” J. Neurol. 242(7): 455–9.
Frye, R. E. and Hait, E. J. (2006). “Air swallowing caused recurrent ileus in Tourette’s syndrome,” Pediatrics 117(6): e1249–52.
Fuh, J. L., Lee, R. C., Wang, S. J., Lin, C. H., Wang, P. N., Chiang, J. H., et al. (1997). “Swallowing difficulty in Parkinson’s disease,” Clin. Neurol. Neurosurg. 99(2): 106–12.
Goetze, O., Nikodem, A. B., Wiezcorek, J., Banasch, M., Przuntek, H., Mueller, T., et al. (2006). “Predictors of gastric emptying in Parkinson’s disease,” J. Neurogastroenterol. Motil. 18(5): 369–75.
Gregory, R. P., Smith, P. T., and Rudge, P. (1992). “Tardive dyskinesia presenting as severe dysphagia,” J. Neurol. Neurosurg. Psychiatry 55(12): 1203–4.
Guneysel, O., Onultan, O., Onur, O. (2008). “Parkinson’s disease and the frequent reasons for emergency admission,” Neuropsychiatr. Dis. Treat. 4(4): 711–14.
Hamilton, J. M., Wolfson, T., Peavy, G. M., Jacobson, M. W., and Corey-Bloom, J. (2004). “Rate and correlates of weight change in Huntington’s disease,” J. Neurol. Neurosurg. Psychiatry 75(2): 209–12.
Hardoff, R., Sula, M., Tamir, A., Soil, A., Front, A., Badarna, S., et al. (2001). “Gastric emptying time and gastric motility in patients with Parkinson’s disease,” Mov. Disord. 16(6): 1041–7.
Heemskerk, A. W. and Roos, R. A. (2011). “Dysphagia in Huntington’s disease: a review,” Dysphagia 26(1): 62–6.
Higo, R., Nito, T., and Tayama, N. (2005). “Swallowing function in patients with multiple-system atrophy with a clinical predominance of cerebellar symptoms (MSA-C),” Eur. Arch. Otorhinolaryngol. 262(8): 646–50.
Higo, R., Tayama, N., Watanabe, T., Nitou, T., and Ugawa, Y. (2003). “Videofluoroscopic and manometric evaluation of swallowing function in patients with multiple system atrophy,” Ann. Otol. Rhinol. Laryngol. 112(7): 630–6.
Hunt, V. P. and Walker, F. O. (1989). “Dysphagia in Huntington’s disease,” J. Neurosci. Nurs. 21(2): 92–5.
Hyson, H. C., Johnson, A. M., and Jog, M. S. (2002). “Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study,” Mov. Disord. 17(6): 1318–20.
Johnston, B. T., Castell, J. A., Stumacher, S., Colcher, A., Gideon, R. M., Li, Q., et al. (1997). “Comparison of swallowing function in Parkinson’s disease and progressive supranuclear palsy,” Mov. Disord. 12(3): 322–7.
Kagel, M. C. and Leopold, N. A. (1992). “Dysphagia in Huntington’s disease: a 16-year retrospective,” Dysphagia 7(2): 106–14.
Kurlan, R., Rothfield, K. P., Woodward, W. R., Nutt, J. G., Miller, C., Lichter, D., et al. (1988). “Erratic gastric emptying of levodopa may cause ‘random’ fluctuations of parkinsonian mobility,” Neurology 38(3): 419–21.
Lagalla, G., Millevolte, M., Capecci, M., Provinciali, L., and Ceravolo, M. G. (2006). “Botulinum toxin type A for drooling in Parkinson’s disease: a double-blind, randomized, placebo-controlled study,” Mov. Disord. 21(5): 704–7.
Lee, W. Y., Yoon, W. T., Shin, H. Y., Jeon, S. H., and Rhee, P. L. (2008). “Helicobacter pylori infection and motor fluctuations in patients with Parkinson’s disease,” Mov. Disord. 23(12): 1696–700.
Lefton-Greif, M. A., Crawford, T. O., Winkelstein, J. A., Loughlin, G. M., Koerner, C. B., Zahurak, M., et al. (2000). “Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia,” J. Pediatr. 136(2): 225–31.
Leopold, N. A. and Kagel, M. C. (1985). “Dysphagia in Huntington’s disease,” Arch. Neurol. 42(1): 57–60.
Leopold, N. A. and Kagel, M. C. (1997). “Dysphagia in progressive supranuclear palsy: radiologic features,” Dysphagia 12(3): 140–3.
Leopold, N. A. and Kagel, M. C. (1997). “Laryngeal deglutition movement in Parkinson’s disease,” Neurology 48(2): 373–6.
Litvan, I., Mangone, C. A., McKee, A., Verny, M., Parsa, A., Jellinger, K., et al. (1996). “Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study,” J. Neurol. Neurosurg. Psychiatry 60(6): 615–20.
Louis, E. D., Marder, K., Jurewicz, E. C., Watner, D., Levy, G., and Mejia-Santana, H. (2002). “Body mass index in essential tremor,” Arch. Neurol. 59(8): 1273–7.
Mathers, S. E., Kempster, P. A., Law, P. J., Frankel, J. P., Bartram, C. I., Lees, A. J., et al. (1989). “Anal sphincter dysfunction in Parkinson’s disease,” Arch. Neurol. 46(10): 1061–4.
Mathers, S. E., Kempster, P. A., Swash, M., and Lees, A. J. (1988). “Constipation and paradoxical puborectalis contraction in anismus and Parkinson’s disease: a dystonic phenomenon?” J. Neurol. Neurosurg. Psychiatry 51(12): 1503–7.
Muller, J., Wenning, G. K., Verny, M., McKee, A., Chaudhuri, K. R., Jellinger, K., et al. (2001). “Progression of dysarthria and dysphagia in post-mortem-confirmed parkinsonian disorders,” Arch. Neurol. 58(2): 259–64.
Nagaya, M., Kachi, T., and Yamada, T. (2000). “Effect of swallowing training on swallowing disorders in Parkinson’s disease,” Scand. J. Rehabil. Med. 32(1): 11–15.
Nilsson, H., Ekberg, O., Olsson, R., and Hindfelt, B. (1996). “Swallowing in hereditary sensory ataxia,” Dysphagia 11(2): 140–3.
Nirenberg, M. J. and Waters, C. (2006). “Compulsive eating and weight gain related to dopamine agonist use,” Mov. Disord. 21(4): 524–9.
Nobrega, A. C., Rodrigues, B., Torres, A. C., Scarpel, R. D., Neves, C. A., and Melo, A. (2008). “Is drooling secondary to a swallowing disorder in patients with Parkinson’s disease?” Park. Rel. Disord. 14(3): 243–5.
Ondo, W. G., Hunter, C., and Moore, W. (2004). “A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease,” Neurology 62(1): 37–40.
Ondo, W. G., Kenney, C., Sullivan, K., Davidson, A., Hunter, C., Jahan, I., et al. (2012). “Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease,” Neurology 78(21): 1650–4.
Ozawa, T., Saji, E., Yajima, R., Onodera, O., and Nishizawa, M. (2011). “Reduced bowel sounds in Parkinson’s disease and multiple system atrophy patients,” Clin. Auton. Res. 21(3): 181–4.
Palace, J., Chandiramani, V. A., and Fowler, C. J. (1997). “Value of sphincter electromyography in the diagnosis of multiple system atrophy,” Muscle Nerve 20(11): 1396–403.
Palmer, J. B., Drennan, J. C., and Baba, M. (2000). “Evaluation and treatment of swallowing impairments,” Am. Fam. Physician 61(8): 2453–62.
Papapetropoulos, S. and Singer, C. (2006). “Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations,” Head Face Med. 2: 47.
Pfeiffer, R. F. (2003). “Gastrointestinal dysfunction in Parkinson’s disease,” Lancet Neurol. 2(2): 107–16.
Pfeiffer, R. F. (2011). “Gastrointestinal dysfunction in Parkinson’s disease,” Park. Rel. Disord. 17(1): 10–15.
Pierantozzi, M., Pietroiusti, A., Brusa, L., Galati, S., Stefani, A., Lunardi, G., et al. (2006). “Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations,” Neurology 66(12): 1824–9.
Potulska, A., Friedman, A., Krolicki, L., and Spychala, A. (2003). “Swallowing disorders in Parkinson’s disease,” Park. Rel. Disord. 9(6): 349–53.
Rickards, H. and Robertson, M. M. (1997). “Vomiting and retching in Gilles de la Tourette syndrome: a report of ten cases and a review of the literature,” Mov. Disord. 12(4): 531–5.
Robbins, J. A., Logemann, J. A., and Kirshner, H. S. (1986). “Swallowing and speech production in Parkinson’s disease,” Ann. Neurol. 19(3): 283–7.
Rub, U., Brunt, E. R., Petrasch-Parwez, E., Schols, L., Theegarten, D., Auburger, G., et al. (2006). “Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7,” Neuropath. Appl. Neuro. 32(6): 635–49.
Saft, C., Andrich, J., Falker, M., Gauda, S., Kuchler, S., Woitalla, D., et al. (2011). “No evidence of impaired gastric emptying in early Huntington’s disease,” PLoS Curr. 3:RRN1284.
Sakakibara, R., Odaka, T., Uchiyama, T., Asahina, M., Yamaguchi, K., Yamaguchi, T., et al. (2003). “Colonic transit time and rectoanal videomanometry in Parkinson’s disease,” J. Neurol. Neurosurg. Psychiatry 74(2): 268–72.
Sakakibara, R., Odaka, T., Uchiyama, T., Liu, R., Asahina, M., Yamaguchi, K., et al. (2004). “Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy,” Mov. Disord. 19(8): 924–9.
Shannon, K. M., Keshavarzian, A., Dodiya, H. B., Jakate, S., and Kordower, J. H. (2012a). “Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases,” Mov. Disord. 27(6): 716–19.
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., et al. (2012b). “Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease,” Mov. Disord. 27(6): 709–15.
Soykan, I. and McCallum, R. W. (1997). “Gastrointestinal involvement in neurologic disorders: stiff-man and Charcot-Marie-Tooth syndromes,” Am. J. Med. Sci. 313(1): 70–3.
Soykan, I., Sarosiek, I., Shifflett, J., Wooten, G., and McCallum, R. (1997). “Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson’s disease,” Mov. Disord. 12(6): 952–7.
Stroudley, J. and Walsh, M. (1991). “Radiological assessment of dysphagia in Parkinson’s disease,” Br. J. Radiol. 64(766): 890–3.
Tanaka, Y., Kato, T., Nishida, H., Yamada, M., Koumura, A., Sakurai, T., et al. (2012). “Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the (13)C-acetate breath test,” J. Neurol. 259(7): 1448–52.
Tezuka, T., Ozawa, T., Takado, Y., Sato, Y., Oyake, M., and Nishizawa, M. (2009). “Megacolon in multiple system atrophy: safety concerns related to PEG,” Mov. Disord. 24(7): 1096–7.
Thomsen, T. R., Galpern, W. R., Asante, A., Arenovich, T., and Fox, S. H. (2007). “Ipratropium bromide spray as treatment for sialorrhea in Parkinson’s disease,” Mov. Disord. 22(15): 2268–73.
Tison, F., Wiart, L., Guatterie, M., Fouillet, N., and Lozano, V. (1996). “Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease,” Mov. Disord. 11(6): 729–32.
Trejo, A., Boll, M. C., Alonso, M. E., Ochoa, A., and Velasquez, L. (2005). “Use of oral nutritional supplements in patients with Huntington’s disease,” Nutrition 21(9): 889–94.
Trejo, A., Tarrats, R. M., Alonso, M. E., Boll, M. C., Ochoa, A., and Velasquez, L. (2004). “Assessment of the nutrition status of patients with Huntington’s disease,” Nutrition 20(2): 192–6.
Tuite, P. J., Maxwell, R. E., Ikramuddin, S., Kotz, C. M., Billington, C. J., Laseski, M. A., et al. (2005). “Weight and body mass index in Parkinson’s disease patients after deep brain stimulation surgery,” Park. Rel. Disord. 11(4): 247–52.
Tumilasci, O. R., Cersosimo, M. G., Belforte, J. E., Micheli, F. E., Benarroch, E. E., and Pazo, J. H. (2006). “Quantitative study of salivary secretion in Parkinson’s disease,” Mov. Disord. 21(5): 660–7.
Van den Eynde, F., Senturk, V., and Naudts, K. (2007). “Gilles de la Tourette syndrome mimicking an eating disorder,” Turk. Psikiyatri. Derg. 18(4): 375–8.
Visser, M., Van Rooden, S. M., Verbaan, D., Stiggelbout, A. M., and Van Hilten, J. J. (2008). “A comprehensive model of health-related quality of life in Parkinson’s disease,” J. Neurol. 255: 1580–7.
Walker, H. C., Lyerly, M., Cutter, G., Hagood, J., Stover, N. P., Guthrie, S. L., et al. (2009). “Weight changes associated with unilateral STN DBS and advanced PD,” Park. Rel. Disord. 15(9): 709–11.
Warnecke, T., Oelenberg, S., Teismann, I., Hamacher, C., Lohmann, H., Ringelstein, E. B., et al. (2010). “Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy,” Mov. Disord. 25(9): 1239–45.
Weinstock, L. B. and Walters, A. S. (2011). “Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth,” Sleep Med. 12(6): 610–13.
Weinstock, L. B. and Zeiss, S. (2012). “Rifaximin antibiotic treatment for restless legs syndrome: a double blind, placebo controlled study,” Sleep Biol. Rhythms. 10(2): 145–53.
Yassa, R. and Nair, N. P. (1987). “The effect of tardive dyskinesia on body weight,” Acta Psychiatr. Scand. 75(2): 209–11.
Zangaglia, R., Martignoni, E., Glorioso, M., Ossola, M., Riboldazzi, G., Calandrella, D., et al. (2007). “Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study,” Mov. Disord. 22(9): 1239–44.
Zibetti, M., Torre, E., Cinquepalmi, A., Rosso, M., Ducati, A., Bergamasco, B., et al. (2007). “Motor and non-motor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus,” Eur. Neurol. 58(4): 218–23.
Cancel
Confirm
×